Observational studyRMD open2022

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.

Simon Kuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.